| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide JMM Walboomers, MV Jacobs, MM Manos, FX Bosch, JA Kummer, ... The Journal of pathology 189 (1), 12-19, 1999 | 12299 | 1999 |
| Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples R Peto, MC Pike, P Armitage, NE Breslow, DR Cox, SV Howard, N Mantel, ... British journal of cancer 35 (1), 1-39, 1977 | 8599 | 1977 |
| Identification of the breast cancer susceptibility gene BRCA2 R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ... Nature 378 (6559), 789-792, 1995 | 4901 | 1995 |
| Prevalence of human papillomavirus in cervical cancer: a worldwide perspective FX Bosch, MM Manos, N Muñoz, M Sherman, AM Jansen, J Peto, ... JNCI: Journal of the National Cancer Institute 87 (11), 796-802, 1995 | 4775 | 1995 |
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ... The American Journal of Human Genetics 72 (5), 1117-1130, 2003 | 4722 | 2003 |
| Asymptotically efficient rank invariant test procedures R Peto, J Peto Journal of the Royal Statistical Society: Series A (General) 135 (2), 185-198, 1972 | 4474 | 1972 |
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3922 | 1998 |
| Localization of a Breast Cancer Susceptibility Gene, BRCA2, to Chromosome 13q12-13 R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ... Science 265 (5181), 2088-2090, 1994 | 2827 | 1994 |
| Genome-wide association study identifies novel breast cancer susceptibility loci DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ... Nature 447 (7148), 1087-1093, 2007 | 2780 | 2007 |
| Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design R Peto, MC Pike, P Armitage, NE Breslow, DR Cox, SV Howard, N Mantel, ... British journal of cancer 34 (6), 585-612, 1976 | 2723 | 1976 |
| Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials G Ronco, J Dillner, KM Elfström, S Tunesi, PJF Snijders, M Arbyn, ... The lancet 383 (9916), 524-532, 2014 | 1868 | 2014 |
| Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women … A Kungu, N Hamajima, K Hirose | 1619 | 2002 |
| Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1315 | 2017 |
| Modeling linkage disequilibrium increases accuracy of polygenic risk scores BJ Vilhjálmsson, J Yang, HK Finucane, A Gusev, S Lindström, S Ripke, ... The american journal of human genetics 97 (4), 576-592, 2015 | 1305 | 2015 |
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013 | 1261 | 2013 |
| The European mesothelioma epidemic J Peto, A Decarli, C La Vecchia, F Levi, E Negri British journal of cancer 79 (3), 666-672, 1999 | 1135 | 1999 |
| Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, DF Easton, ... Journal of the National Cancer Institute 91 (11), 943-949, 1999 | 1130 | 1999 |
| The cervical cancer epidemic that screening has prevented in the UK J Peto, C Gilham, O Fletcher, FE Matthews The Lancet 364 (9430), 249-256, 2004 | 1043 | 2004 |
| Cancer epidemiology in the last century and the next decade J Peto Nature 411 (6835), 390-395, 2001 | 1018 | 2001 |
| Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer M Arbyn, G Ronco, A Anttila, CJLM Meijer, M Poljak, G Ogilvie, ... Vaccine 30, F88-F99, 2012 | 966 | 2012 |
